ROCKET PHARMACEUTICALS, INC. (RCKT)
Rocket Pharmaceuticals Announces FDA Approval of KRESLADI™ for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I)
FORGENT POWER SOLUTIONS, INC. (FPS)
Forgent Power Solutions Announces Pricing of Public Offering of Class A Common Stock
SSR MINING INC. (SSRM)
SSR Mining Announces Normal Course Issuer Bid
SATELLOS BIOSCIENCE INC. (MSCLF)
Satellos Reports 2025 Financial Results and Highlights Recent Company Progress
DOUBLEDOWN INTERACTIVE CO., LTD. (DDI)
DoubleDown Interactive Announces Results of 2026 Annual General Meeting
INSTIL BIO, INC. (TIL)
Instil Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
WEREWOLF THERAPEUTICS, INC. (HOWL)
Werewolf Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates
PARAZERO TECHNOLOGIES LTD. (PRZO)
ParaZero Issues CEO Letter to Shareholders: Reports Strong Revenue Growth for Full Year 2025
AUTOLUS THERAPEUTICS PLC (AUTL)
Autolus Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates
EDITAS MEDICINE, INC. (EDIT)
Editas Medicine Announces U.S. Patent and Trademark Office Reaffirms its Prior Decision in Favor of the Broad Institute in CRISPR/Cas9 Interference